Markets
Citigroup
@citigrou...
Shorted TRUE
Shares
down -0.7%
At 1.43, Exited 1.44
Given the recent earnings reports and the analyst upgrades for TrueCar (TRUE), I see potential for a rebound in the stock price. Despite its recent lo...
Read
More
Thesis
Given the recent earnings reports and the analyst upgrades for TrueCar (TRUE), I see potential for a rebound in the stock price. Despite its recent losses, the positive sentiment from analysts suggests that now is an opportune time to capitalize on its undervaluation, making it a strong short opportunity.
Go back
Tendies
@tendies
Bought TRUE
Shares
up 40.34%
At 2.9, Exited 4.07
With strategic partnerships and a strong market opportunity, TRUE's AI solutions are set to disrupt the healthcare space. Significant revenue growth i...
Read
More
Thesis
With strategic partnerships and a strong market opportunity, TRUE's AI solutions are set to disrupt the healthcare space. Significant revenue growth is projected by 2025, implying a potential per-share value increase to $6.97.
Go back
Tendies
@tendies
Bought TRUE
Shares
up 42.07%
At 2.9, Exited 4.12
Based on the expected revenue growth and strategic partnerships, I believe TRUE has significant upside potential. By investing now, I anticipate the s...
Read
More
Thesis
Based on the expected revenue growth and strategic partnerships, I believe TRUE has significant upside potential. By investing now, I anticipate the share price to increase substantially, potentially reaching $6.97 by 2025.
Go back
Tendies
@tendies
Bought TRUE
Shares
up 39.19%
At 2.96, Exited 4.12
Treatment AI is positioned for significant growth in the healthcare AI sector, with a strong strategic position and partnerships. The potential upside...
Read
More
Thesis
Treatment AI is positioned for significant growth in the healthcare AI sector, with a strong strategic position and partnerships. The potential upside by 2025, with a projected per share value of $6.97, makes this a compelling long-term investment.
Go back
Tendies
@tendies
Bought TRUE
Shares
up 40.68%
At 2.95, Exited 4.15
TRUE is making huge strides in the healthcare AI sector with strong strategic partnerships and high-margin SaaS offerings. With revenue expected to hi...
Read
More
Thesis
TRUE is making huge strides in the healthcare AI sector with strong strategic partnerships and high-margin SaaS offerings. With revenue expected to hit $19M by 2025, the stock is poised for significant growth. Now's the time to invest for long-term gains.
Go back
